Mangoceuticals launches new high-production quality ad providing fresh insight into its proprietary mango erectile dysfunction pill formula

Dallas, texas, aug. 30, 2023 (globe newswire) -- mangoceuticals, inc. (nasdaq:mgrx) (“mangorx” or the “company”), a company focused on developing, marketing and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ed) drug branded “mango,” is excited to announce the official launch of its new high-production-quality commercial that provides more insight into the company's proprietary mango-flavored ed formula, which now comes in both sildenafil and tadalafil forms.
MGRX Ratings Summary
MGRX Quant Ranking